GTI Reports Q2 2026 Financial Results

CHCAGO – Green Thumb Industries Inc. reported Q2 2026 revenue of $306.7 million, clearing Wall Street’s consensus estimate of $298.99 million by roughly $8 million. The result represented a 4.6% year-over-year gain, driven primarily by adult-use sales growth in Minnesota alongside continued performance in Connecticut, Florida, and Ohio.

GAAP net income swung to $4.9 million, or $0.02 per basic and diluted share, from a net loss of $0.6 million, or $0.01 per share, in the same quarter a year earlier. Normalized EBITDA was $84.3 million, or 27.5% of revenue, down marginally from 28.2% a year prior. Cash from operations totaled $29 million, and the company held $283.6 million in cash at quarter end. Green Thumb also repurchased the equivalent of approximately 7.9 million Subordinate Voting Shares for $48.3 million during Q2, at an average price of $6.11 per share. Shares rose 2.44% to $10.09 in after-hours trading following the release.

Gross margin fell to 45% from 49.9% a year earlier, pulled down by RYTHM brand licensing fees incurred in the current period and price compression across key markets, including Massachusetts, New Jersey, and Pennsylvania. Same-store sales on a base of 103 stores decreased 1.1% versus the prior year.

Virginia took the spotlight in the company’s forward narrative. Adult-use sales were authorized beginning July 1, 2027, where the company has operated since 2021 and holds one of five vertically integrated medical Cannabis licenses, six RISE dispensaries, and a grower-processor facility. Management drew comparisons to its early positioning in Minnesota, Maryland, and Ohio ahead of each state’s adult-use transition.

Texas added another layer of optionality. Green Thumb received a conditional license under the state’s Compassionate Use Program in April, with market entry groundwork underway through Q2. CEO Ben Kovler noted that Virginia and Texas together account for roughly 12% of the U.S. population.

Retail expansion also continued post-quarter. Adult-use sales launched at RISE Dispensary Paramus in New Jersey on July 13, and RISE Dispensary Hanover in Pennsylvania opened July 31, bringing the total retail footprint past 120 locations.

Management pointed to Ohio’s regulated market as an early indicator of what a national hemp crackdown could produce, following the state’s own ban on intoxicating hemp products, most such products were removed from retail and consumers moved into the licensed Cannabis channel. For Q3 2026, management guided to flat sequential revenue, citing the current pricing environment.

Green Thumb’s Q2 results confirm its standing as one of the more resilient MSOs working through persistent pricing headwinds. The revenue beat was clean, the balance sheet is well-stocked, and its foothold in Virginia and Texas represents real near-term growth optionality. Margin compression looks largely mechanical, tied to a new licensing fee structure rather than operational deterioration. The second-half variable to watch is the federal hemp ban. If it sticks and draws consumers into licensed channels the way Ohio did, Green Thumb’s scale, brands, and retail footprint put it in a strong position to capture that demand.